Heritage Trust CO Neurocrine Biosciences Inc Transaction History

Heritage Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$86.18 - $99.03 $587,316 - $674,889	-6,815 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$89.43 - $102.27 $97,478 - $111,474	-1,090 Reduced 13.79%	6,815 $663,000
Q1 2021 May 12, 2021	BUY	$87.57 - $119.4 $12,259 - $16,716	140 Added 1.8%	7,905 $769,000
Q4 2020 Feb 11, 2021	BUY	$86.91 - $108.33 $434 - $541	5 Added 0.06%	7,765 $744,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $26,924 - $37,842	280 Added 3.74%	7,760 $746,000
Q2 2020 Aug 04, 2020	BUY	$85.09 - $130.36 $636,473 - $975,092	7,480 New	7,480 $913,000
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $14,693 - $19,404	-212 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$68.32 - $124.36 $7,651 - $13,928	112 Added 112.0%	212 $15,000
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $4,152 - $5,285	42 Added 72.41%	100 $12,000
Q2 2018 Aug 15, 2018	BUY	$75.3 - $105.99 $4,367 - $6,147	58 New	58 $6,000

641

95.3M

661K

227K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

Stay updated on Heritage Trust CO with notifications on news.